Nucleus Capital

Total investments

21

Average round size

3M

Portfolio companies

19

Rounds per year

5.25

Lead investments

1

Follow on index

0.10

Stages of investment
Seed
Areas of investment
LogisticsBiotechnologyInternetSupply Chain ManagementTransportationInformation TechnologyFood and BeverageFood ProcessingManufacturingMarketing

Investments analytics

Analytics

Total investments
21
Lead investments
1
Rounds per year
5.25
Follow on index
0.10
Investments by industry
  • Biotechnology (4)
  • Food and Beverage (3)
  • Information Technology (3)
  • Supply Chain Management (3)
  • Internet (2)
  • Show 30 more
Investments by region
  • Germany (7)
  • United States (3)
  • The Netherlands (2)
  • Switzerland (1)
  • United Kingdom (4)
Peak activity year
2022

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
2
Group Appearance index
0.95

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Concert Bio 01 Aug 2022 Biotechnology Seed 1M England, London, United Kingdom
ROKT 30 Oct 2019 Business/Productivity Software, Media and Information Services (B2B), E-Commerce, B2B, Marketing Automation, Big Data, Data Integration, Market Research, Advertising Platforms Late Stage Venture 48M United States, New York, New York
Trilobio 29 Nov 2023 Seed 3M United States, California, San Francisco
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.